CELATOR PHARMACEUTICALS INC's ticker is CPXX and the CUSIP is 15089R102. A total of 20 filers reported holding CELATOR PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $67,370,000 | +163.0% | 2,232,272 | -3.9% | 76.00% | +115.0% |
| Q1 2016 | $25,620,000 | +548.0% | 2,322,769 | +3.4% | 35.36% | +113.2% |
| Q4 2015 | $3,954,000 | +6.0% | 2,246,469 | 0.0% | 16.59% | +229.7% |
| Q3 2015 | $3,729,000 | -25.9% | 2,246,469 | 0.0% | 5.03% | -5.6% |
| Q2 2015 | $5,032,000 | -9.3% | 2,246,469 | 0.0% | 5.33% | -19.6% |
| Q1 2015 | $5,549,000 | +26.0% | 2,246,469 | 0.0% | 6.62% | +30.7% |
| Q4 2014 | $4,403,000 | -22.5% | 2,246,469 | 0.0% | 5.06% | -13.4% |
| Q3 2014 | $5,684,000 | -14.5% | 2,246,469 | 0.0% | 5.85% | +14.1% |
| Q2 2014 | $6,650,000 | -6.6% | 2,246,469 | 0.0% | 5.13% | -5.7% |
| Q1 2014 | $7,121,000 | -2.5% | 2,246,469 | 0.0% | 5.44% | +17.2% |
| Q4 2013 | $7,301,000 | – | 2,246,469 | – | 4.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,322,769 | $25,620,000 | 35.36% |
| Boxer Capital, LLC | 835,408 | $9,215,000 | 9.02% |
| Avoro Capital Advisors LLC | 1,416,257 | $15,621,000 | 5.45% |
| EcoR1 Capital, LLC | 950,000 | $10,479,000 | 3.66% |
| ACUTA CAPITAL PARTNERS, LLC | 500,000 | $5,515,000 | 3.08% |
| BVF INC/IL | 800,000 | $8,824,000 | 2.18% |
| Hatteras Investment Partners, LP | 70,720 | $780,000 | 2.13% |
| RA Capital Management | 1,414,114 | $15,598,000 | 1.99% |
| Connective Capital Management, LLC | 54,100 | $596,000 | 1.85% |
| Perceptive Advisors | 1,100,000 | $12,133,000 | 1.06% |